Vestal-Point-Capital-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  null,
  "KNSA",
  "NUVL",
  "ASND",
  "CNTA",
  "INSM",
  "FOLD",
  "ARCT",
  "GLPG",
  "BCAX",
  "ATXS",
  "GPCR",
  "IMTX",
  "SVRA",
  "TYRA",
  "LQDA",
  "NRIX",
  "ANRO",
  "ALEC",
  "APLT",
  "ATRA",
  "ESTA",
  "GERN",
  "SRRK",
  "FATE",
  "KALV",
  "MGNX",
  "LXEO",
  "OKUR",
  "STRO",
  "ZYME",
  "GEHC",
  "TRAW",
  "SLDB",
  "TENX",
  "MLTX",
  "ACLX",
  "QURE",
  "COGT",
  "DYN",
  "PASG",
  "GMED",
  "SRPT",
  "PRGO",
  null,
  "CDTX",
  "ITOS",
  "URGN",
  "VRNA",
  "VTYX",
  "VYGR",
  "XENE",
  "VERA",
  "RARE",
  "IMVT",
  "BDTX",
  "BRKR",
  "CLDX",
  "CRNX",
  "DHR",
  "DAWN",
  "CYTK",
  "DNTH"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 63
Total Value: 1400316542
Accession Number: 0001974915-25-000005
Form Type: 13F-HR
CIK: vestal-point-capital-lp
Manager Name: Vestal-Point-Capital-Lp

Data Enrichment

97% identified

61 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

63 positions • $1.4B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 4

Sort by:

Ascendis Pharma A/S

ASND|04351P101

Shares:150.1K

Value:$23.4M

% of Portfolio:1.7% ($23.4M/$1.4B)

Astria Therapeutics, Inc.

ATXS|04635X102

Shares:4.2M

Value:$22.3M

% of Portfolio:1.6% ($22.3M/$1.4B)

Day One Biopharmaceuticals, Inc.

DAWN|23954D109

Shares:2.6M

Value:$20.6M

% of Portfolio:1.5% ($20.6M/$1.4B)

Dyne Therapeutics, Inc.

DYN|26818M108

Shares:1.8M

Value:$18.8M

% of Portfolio:1.3% ($18.8M/$1.4B)

Ultragenyx Pharmaceutical Inc.

RARE|90400D108

Shares:500.0K

Value:$18.1M

% of Portfolio:1.3% ($18.1M/$1.4B)

Liquidia Corp

LQDA|53635D202

Shares:1.2M

Value:$18.1M

% of Portfolio:1.3% ($18.1M/$1.4B)

Cogent Biosciences, Inc.

COGT|19240Q201

Shares:3.0M

Value:$18.0M

% of Portfolio:1.3% ($18.0M/$1.4B)

ESTABLISHMENT LABS HOLDINGS INC.

ESTA|G31249108

Shares:433.2K

Value:$17.7M

% of Portfolio:1.3% ($17.7M/$1.4B)

Verona Pharma plc

VRNA|925050106

Shares:267.6K

Value:$17.0M

% of Portfolio:1.2% ($17.0M/$1.4B)

PERRIGO Co plc

PRGO|G97822103

Shares:587.6K

Value:$16.5M

% of Portfolio:1.2% ($16.5M/$1.4B)

GE HealthCare Technologies Inc.

GEHC|36266G107

Shares:204.1K

Value:$16.5M

% of Portfolio:1.2% ($16.5M/$1.4B)

B6S7WD106

Shares:2.3M

Value:$16.2M

% of Portfolio:1.2% ($16.2M/$1.4B)

GLOBUS MEDICAL INC

GMED|379577208

Shares:200.0K

Value:$14.6M

% of Portfolio:1.0% ($14.6M/$1.4B)

Nurix Therapeutics, Inc.

NRIX|67080M103

Shares:1.1M

Value:$13.4M

% of Portfolio:1.0% ($13.4M/$1.4B)

Sarepta Therapeutics, Inc.

SRPT|803607100

Shares:200.0K

Value:$12.8M

% of Portfolio:0.9% ($12.8M/$1.4B)

BRUKER CORP

BRKR|116794108

Shares:300.0K

Value:$12.5M

% of Portfolio:0.9% ($12.5M/$1.4B)

Cidara Therapeutics, Inc.

CDTX|171757206

Shares:504.5K

Value:$10.9M

% of Portfolio:0.8% ($10.9M/$1.4B)

Black Diamond Therapeutics, Inc.

BDTX|09203E105

Shares:5.6M

Value:$8.7M

% of Portfolio:0.6% ($8.7M/$1.4B)

MoonLake Immunotherapeutics

MLTX|61559X104

Shares:200.0K

Value:$7.8M

% of Portfolio:0.6% ($7.8M/$1.4B)

Solid Biosciences Inc.

SLDB|83422E204

Shares:1.8M

Value:$6.5M

% of Portfolio:0.5% ($6.5M/$1.4B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Ascendis Pharma A/S(ASNDcusip04351P101)	150.1K	QoQ -71.12% (-369.9K) YoY -71.40% (-374.9K)	All Managers (Combined)	$23.4M	1.7% ($23.4M/$1.4B)	QoQ -67.31% (-$48.2M) YoY -70.51% (-$56.0M)
Astria Therapeutics, Inc.(ATXScusip04635X102)	4.2M	QoQ 0.00% (-0) YoY +280.00% (+3.1M)	All Managers (Combined)	$22.3M	1.6% ($22.3M/$1.4B)	QoQ -40.26% (-$15.0M) YoY +44.17% (+$6.8M)
Day One Biopharmaceuticals, Inc.(DAWNcusip23954D109)	2.6M	QoQ +80.42% (+1.2M) YoY NEW(+2.6M)	All Managers (Combined)	$20.6M	1.5% ($20.6M/$1.4B)	QoQ +12.92% (+$2.4M) YoY NEW(+$20.6M)
Dyne Therapeutics, Inc.(DYNcusip26818M108)	1.8M	QoQ NEW(+1.8M) YoY NEW(+1.8M)	All Managers (Combined)	$18.8M	1.3% ($18.8M/$1.4B)	QoQ NEW(+$18.8M) YoY NEW(+$18.8M)
Ultragenyx Pharmaceutical Inc.(RAREcusip90400D108)	500.0K	QoQ -66.66% (-1.0M) YoY +354.54% (+390.0K)	All Managers (Combined)	$18.1M	1.3% ($18.1M/$1.4B)	QoQ -71.30% (-$45.0M) YoY +252.51% (+$13.0M)
Liquidia Corp(LQDAcusip53635D202)	1.2M	QoQ -30.26% (-532.6K) YoY -38.62% (-772.6K)	All Managers (Combined)	$18.1M	1.3% ($18.1M/$1.4B)	QoQ -12.52% (-$2.6M) YoY -38.62% (-$11.4M)
Cogent Biosciences, Inc.(COGTcusip19240Q201)	3.0M	QoQ NEW(+3.0M) YoY NEW(+3.0M)	All Managers (Combined)	$18.0M	1.3% ($18.0M/$1.4B)	QoQ NEW(+$18.0M) YoY NEW(+$18.0M)
ESTABLISHMENT LABS HOLDINGS INC.(ESTAcusipG31249108)	433.2K	QoQ +44.39% (+133.2K) YoY NEW(+433.2K)	All Managers (Combined)	$17.7M	1.3% ($17.7M/$1.4B)	QoQ +27.89% (+$3.9M) YoY NEW(+$17.7M)
Verona Pharma plc(VRNAcusip925050106)	267.6K	QoQ -45.93% (-227.4K) YoY NEW(+267.6K)	All Managers (Combined)	$17.0M	1.2% ($17.0M/$1.4B)	QoQ -26.08% (-$6.0M) YoY NEW(+$17.0M)
PERRIGO Co plc(PRGOcusipG97822103)	587.6K	QoQ +56.70% (+212.6K) YoY NEW(+587.6K)	All Managers (Combined)	$16.5M	1.2% ($16.5M/$1.4B)	QoQ +70.90% (+$6.8M) YoY NEW(+$16.5M)
GE HealthCare Technologies Inc.(GEHCcusip36266G107)	204.1K	QoQ NEW(+204.1K) YoY NEW(+204.1K)	All Managers (Combined)	$16.5M	1.2% ($16.5M/$1.4B)	QoQ NEW(+$16.5M) YoY NEW(+$16.5M)
(cusipB6S7WD106)✕	2.3M	QoQ -20.69% (-605.3K) YoY NEW(+2.3M)	All Managers (Combined)	$16.2M	1.2% ($16.2M/$1.4B)	QoQ -30.80% (-$7.2M) YoY NEW(+$16.2M)
GLOBUS MEDICAL INC(GMEDcusip379577208)	200.0K	QoQ -38.46% (-125.0K) YoY -80.00% (-800.0K)	All Managers (Combined)	$14.6M	1.0% ($14.6M/$1.4B)	QoQ -45.53% (-$12.2M) YoY -72.70% (-$39.0M)
Nurix Therapeutics, Inc.(NRIXcusip67080M103)	1.1M	QoQ +132.07% (+640.6K) YoY NEW(+1.1M)	All Managers (Combined)	$13.4M	1.0% ($13.4M/$1.4B)	QoQ +46.33% (+$4.2M) YoY NEW(+$13.4M)
Sarepta Therapeutics, Inc.(SRPTcusip803607100)	200.0K	QoQ -20.00% (-50.0K) YoY +100.00% (-100.0K)	All Managers (Combined)	$12.8M	0.9% ($12.8M/$1.4B)	QoQ -58.00% (-$17.6M) YoY -1.40% (-$182.0K)
BRUKER CORP(BRKRcusip116794108)	300.0K	QoQ NEW(+300.0K) YoY NEW(+300.0K)	All Managers (Combined)	$12.5M	0.9% ($12.5M/$1.4B)	QoQ NEW(+$12.5M) YoY NEW(+$12.5M)
Cidara Therapeutics, Inc.(CDTXcusip171757206)	504.5K	QoQ NEW(+504.5K) YoY NEW(+504.5K)	All Managers (Combined)	$10.9M	0.8% ($10.9M/$1.4B)	QoQ NEW(+$10.9M) YoY NEW(+$10.9M)
Black Diamond Therapeutics, Inc.(BDTXcusip09203E105)	5.6M	QoQ 0.00% (-0) YoY NEW(+5.6M)	All Managers (Combined)	$8.7M	0.6% ($8.7M/$1.4B)	QoQ -27.57% (-$3.3M) YoY NEW(+$8.7M)
MoonLake Immunotherapeutics(MLTXcusip61559X104)	200.0K	QoQ NEW(+200.0K) YoY NEW(+200.0K)	All Managers (Combined)	$7.8M	0.6% ($7.8M/$1.4B)	QoQ NEW(+$7.8M) YoY NEW(+$7.8M)
Solid Biosciences Inc.(SLDBcusip83422E204)	1.8M	QoQ -38.47% (-1.1M) YoY +69.42% (-718.6K)	All Managers (Combined)	$6.5M	0.5% ($6.5M/$1.4B)	QoQ -43.08% (-$4.9M) YoY -52.93% (-$7.3M)